Sulkowski MS - Search Results

1

Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial.

Sulkowski MS, Felizarta F, Smith C, Slim J, Berggren R, Goodman R, Ball L, Khalili M, Dieterich DT; Hepatitis Resource Network Clinical Trials Group. Sulkowski MS, et al. J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):464-72. doi: 10.1097/00126334-200404150-00004. J Acquir Immune Defic Syndr. 2004. PMID: 15021311 Clinical Trial.

2

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.

Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Sulkowski MS, et al. JAMA. 2000 Jan 5;283(1):74-80. doi: 10.1001/jama.283.1.74. JAMA. 2000. PMID: 10632283

3

Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus.

Sulkowski MS, Mast EE, Seeff LB, Thomas DL. Sulkowski MS, et al. Clin Infect Dis. 2000 Apr;30 Suppl 1:S77-84. doi: 10.1086/313842. Clin Infect Dis. 2000. PMID: 10770916 Review.

4

Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: A meta-analysis of randomized trials.

Cummings KJ, Lee SM, West ES, Cid-Ruzafa J, Fein SG, Aoki Y, Sulkowski MS, Goodman SN. Cummings KJ, et al. Among authors: sulkowski ms. JAMA. 2001 Jan 10;285(2):193-9. doi: 10.1001/jama.285.2.193. JAMA. 2001. PMID: 11176813 Review.

5

HIV and hepatitis C virus co-infection.

Sulkowski M. Sulkowski M. Hopkins HIV Rep. 1998 Nov;10(6):8, 12. Hopkins HIV Rep. 1998. PMID: 11366132

6

Hepatitis C Virus Infection in HIV-infected Patients.

Sulkowski MS. Sulkowski MS. Curr Infect Dis Rep. 2001 Oct;3(5):469-476. Curr Infect Dis Rep. 2001. PMID: 11559468

7

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.

Soriano V, Sulkowski M, Bergin C, Hatzakis A, Cacoub P, Katlama C, Cargnel A, Mauss S, Dieterich D, Moreno S, Ferrari C, Poynard T, Rockstroh J. Soriano V, et al. AIDS. 2002 Apr 12;16(6):813-28. doi: 10.1097/00002030-200204120-00001. AIDS. 2002. PMID: 11919483 Review. No abstract available.

8

Peginterferon-alpha-2a (40kD) and ribavirin in patients with chronic hepatitis C: a phase II open-label study.

Sulkowski M, Reindollar R, Thomas DL, Brinkley-Laughton S, Hudson M, Yu J. Sulkowski M, et al. BioDrugs. 2002;16(2):105-9. doi: 10.2165/00063030-200216020-00004. BioDrugs. 2002. PMID: 11985484 Clinical Trial.

9

Needlestick transmission of hepatitis C.

Sulkowski MS, Ray SC, Thomas DL. Sulkowski MS, et al. JAMA. 2002 May 8;287(18):2406-13. doi: 10.1001/jama.287.18.2406. JAMA. 2002. PMID: 11988061

10

Hepatitis C and progression of HIV disease.

Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Sulkowski MS, et al. JAMA. 2002 Jul 10;288(2):199-206. doi: 10.1001/jama.288.2.199. JAMA. 2002. PMID: 12095384

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

359 results

Search Page